The economic burden of gout on an employed population

References

• Harris MD, Siegel LB, Alloway JA. Gout and hyperuricemia. Am Fam Physician 1999;59:925–34
   PubMed Web of Science ®Google Scholar
• Roubenoff R, Klag MJ, Mead LA, et al. Incidence and risk factors for gout in white men. JAMA 1991;266:3004–7
   PubMed Web of Science ®Google Scholar
• Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988–1994. Am J Kidney Dis 2002;40:37–42
   PubMed Web of Science ®Google Scholar
• Adams PF, Hendershot GE, Marano MA. Centers for Disease Control and Prevention/National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10 1999;200: 1–203
   Google Scholar
• Troen BR. The biology of aging. Mt Sinai J Med 2003;70: 3–22
   PubMed Web of Science ®Google Scholar
• Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyper-uricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421–6
   Google Scholar
• Choi HK, Atkinson K, Karlson EW, et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004;363:1277–81
   PubMed Web of Science ®Google Scholar
• Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093–103
   PubMed Web of Science ®Google Scholar
• Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the US, 1998–2000. JAMA 2003;290:199–206
   PubMed Web of Science ®Google Scholar
• Tykarski A. Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron 1991;59:364–8
   PubMed Web of Science ®Google Scholar
• Bedir A, Topbas M, Tanyeri F, et al. Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 2003;44:527–36
   PubMedGoogle Scholar
• Ferdinand KC. Recommendations for the management of special populations: racial and ethnic populations. Am J Hypertens 2005;16:50S–4S
   Google Scholar
• Choi HK, Curhan G. Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol 2005;17:341–5
   PubMed Web of Science ®Google Scholar
• Caspi D, Lubart E, Habot B, et al. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000;43:103–8
   PubMed Web of Science ®Google Scholar
• Reginato AJ. Gout and other crystal arthropathies. In: Braunwald E, Fauci AS, Kasper DL, et al., editors. Harrison’s principles of internal medicine. 15th edn. New York: McGraw-Hill, 2001. p.1995
   Google Scholar
• Riedel AA, Nelson M, Joseph-Ridge N, et al. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol 2004;31:1575–81
   Google Scholar
• Schlesinger N. Management of acute and chronic gouty arthritis: present state-of-the art. Drugs 2004;64:2399–416
   PubMed Web of Science ®Google Scholar
• Kim KY, Schumacher HR, Hunsche E, et al. A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003;25:1593–617
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Prevalence of leisure-time physical activity among persons with arthritis and other rheumatic conditions – United States, 1990–1991. MMWR: Morb Mortal Wkly Rep 1997;46: 389–93
   Google Scholar
• Mikuls TR, Farrar JT, Bilker WB, et al. Gout epidemiology: results from the UK General Practice Research Database, 1990–1999. Ann Rheum Dis 2005;64:267–72
   PubMed Web of Science ®Google Scholar
• Stave GM, Muchmore L, Gardner HH. Quantifiable impact of the contract for health and wellness: health care costs, disability, and workers’ compensation. Health behaviors, health care costs, disability, and workers’ compensation. J Occup Environ Med 2003;45:109–17
   Google Scholar
• Muchmore L, Lynch WD, Gardner HH, et al. Prevalence of arthritis and associated joint disorders in an employed population and the associated healthcare, sick leave, and workers’ compensation benefits cost and productivity loss of employers. J Occup Environ Med 2003;45:369–78
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Palmer L. Clinical classifications software, 2004. U.S. Agency for Healthcare and Research. Available from http://www.ahrq.gov/data/hcup/css.htm#download [Last accessed November 2004]. Also available through HCUP Methods Series: Report #2004–02 Comorbidity software documentation. Available from http://www.hcup-us.ahrq.gov/reports/methods.jsp [Last accessed November 2004]
   Google Scholar
• Blough D, Madden C, Hornbrook M. Modeling risk using generalized linear models. J Health Econ 1999;18:153–71
   Google Scholar
• Lawrence RC, Hochberg MC, Kelsey JL, et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989;16:427–41
   PubMed Web of Science ®Google Scholar
• Wilder MH. Prevalence of chronic skin and musculoskeletal conditions, United States – 1969. Vital and Health Statistics 10 1974;92
   Google Scholar
• Wallace KL, Riedel AA, Joseph-Ridge N, et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31: 1582–7
   Google Scholar
• Employment status of the civilian noninstitutional population by age, sex, and race. Available from ftp://ftp.bls.gov/pub/special. requests/lf/aa2004/aat3.txt [Last accessed 6 April 2006]
   Google Scholar
• Median weekly earnings of full-time wage and salary workers by selected characteristics. Available from ftp://ftp.bls.gov/pub/ special.requests/lf/aa2004/aat37.txt [Last accessed 6 April 2006]
   Google Scholar
• Gignac MA. Arthritis and employment: an examination of behavioral coping efforts to manage workplace activity limitations. Arthritis Rheum 2005;53:328–36
   PubMed Web of Science ®Google Scholar
• Pascual E, Jovani V. Synovial fluid analysis. Best Pract Res Clin Rheumatol 2005;19:371–86
   PubMed Web of Science ®Google Scholar
• Bieber JD, Terkeltaub RA. Gout on the brink of novel therapeutic options for an ancient disease. Art Rheum 2004;50:2400–14
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735–52
   PubMed Web of Science ®Google Scholar
• Novak S. A comparison of average annual medical services for comorbid conditions associated with metabolic syndrome found in employees with gout versus those without gout. J Manag Care Pharm 2006;12:173
   Google Scholar
• US Census Bureau. Annual estimates of the population by selected age groups and sex for the United States: April 1, 2000 to July 1, 2004. Available from http://www.census.gov/popest/national/asrh/NC-EST2004-sa.html [Last accessed August 2005]
   Google Scholar
• Kaiser State health facts. Org: 50 state comparisons – population distribution by insurance status 2003. Available from http://www.statehealthfacts.org [Last accessed August 2005]
   Google Scholar
• US Census Bureau. United States civilian labor force. Available from http://webs.wichita.edu/cedbr/usclf.PDF#search=‘United%2 0states%20civilian%20labor%20 force [Last accessed July 2005]
   Google Scholar
• Emmerson BT. The management of gout. N Engl J Med 1996;334:445–51
   PubMed Web of Science ®Google Scholar
• Perez-Ruiz F, Alonso-Ruiz A, Calabozo M, et al. Efficacy of allopurinol and benzbromarone for the control of hyperuricemia. A pathogenic approach to the treatment of primary chronic gout. Ann Rheum Dis 1998;57:545–9
   Google Scholar
• Sarawate CA, Patel PA, Schumacher HR, at al. Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol 2006;12:61–5
   PubMed Web of Science ®Google Scholar